Newsroom
  • July 15 , 2020

    Immunotherapy with CAR T cells results in exceptional patient recovery

    In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2 protein on the surface of the cancer cells.
    Read more
  • July 14 , 2020

    First Coronavirus Vaccine Tested in Humans Shows Early Promise

    An experimental coronavirus vaccine made by the biotech company Moderna provoked a promising immune response against the virus and appeared safe in the first 45 people who received it, researchers reported on Tuesday in The New England Journal of Medicine.
    Read more
  • July 13 , 2020

    Amgen Announces Additional Investment In BeiGene

    Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares
    Read more
  • July 13 , 2020

    Cancer Stakeholders Call for Consensus of Terms to Encourage Patients’ Genetic Testing

    Read more
  • July 13 , 2020

    Coronavirus vaccine update: Bharat Biotech starts human trials; Russia successfully completes human testing

    As global efforts are on to develop a safe and affordable COVID-19 vaccine, the big question remains unanswered: When will it be ready? India, which is only behind the United States and Brazil in coronavirus numbers, is also quickening up its pace to find a potent drug as early as possible. However, since the Centre is yet to announce a national policy on CO
    Read more
  • July 13 , 2020

    Massachusetts biotech Revitope scores first collaboration thanks to dual-engaging T cell platform

    Revitope Oncology began 2020 hopeful that its cancer immunology platform would be finally ready to flourish. On Monday night, that platform nabbed the biotech its first collaboration.
    Read more
  • July 12 , 2020

    Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders

    The Data Demonstrating Benefits of Pharmacokinetic-Guided Prophylaxis Therapy in Hemophilia and von Willebrand Disease are Among 13 Presentations from Takeda’s Hematology Portfolio and Pipeline
    Read more
  • July 8 , 2020

    Contract Research Organization (CRO) Market in China 2020 Analysis to 2024 – Application, Emerging Trends and Leading Players

    China CRO market value is anticipated to reach US$27.04 billion in 2024, growing at a CAGR of 27.06%, for the period spanning from 2020 to 2024.
    Read more
  • June 26 , 2020

    The Fed put new restrictions on US banks. Some want it to go further

    London (CNN Business) Regulators have made clear that the US banking system is in much better shape than it was during the 2008 financial crisis, and should have enough money on hand to keep lending to customers in support of the economic recovery.
    Read more
  • June 5 , 2020

    Atlas banks $400M in its latest 'breakthrough biotech' fund

    If there’s anything this pandemic has taught us, it's that biotech—and its investors—will not be stopped.
    Read more
  • May 18 , 2020

    Early results from Moderna coronavirus vaccine trial show participants developed antibodies against the virus

    Volunteers who received Moderna's Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health to develop the vaccine.
    Read more
  • April 2 , 2020

    Inequality doesn't just make pandemics worse – it could cause them

    Whether these measures are justified by the threat Covid-19 poses to human life is impossible to say, but those who imposed them knew there would be a high price to pay.
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us